Multiple Sclerosis companies are Immune Response BioPharma, Clene Nanomedicine, Genzyme, ImStem Biotechnology, Rho, Inc., ...
MPM BioImpact, a biotechnology investment firm creating and investing in innovative companies seeking to deliver ...
24/7 Wall St. on MSN36m
Merck Just Paid Investors: How Much Did They Receive?Merck & Co. Inc. (NYSE: MRK) is rewarding its shareholders once again with a quarterly dividend of $0.81 per share, payable ...
Fexlamose is being developed as a chronic treatment for COPD and asthma in conjunction with standard therapies, to improve ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback